• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership
Step aside Wall Street, small pharma CEO pay reaches for the sky
By Paul HodgsonJanuary 5, 2015
Health workers in protective equipment handle a sample taken from the body of someone who is suspected to have died from Ebola virus, near Rokupa Hospital
Features
Roche wins FDA emergency approval for Ebola test
By Laura LorenzettiDecember 29, 2014
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
Roche shares tumble after Alzheimer’s drug failure
By ReutersDecember 19, 2014
Inside Rite Aid Ahead of Earnings Reports
Features
Rite Aid’s healthcare investments are paying off
By Laura LorenzettiDecember 18, 2014
Drug-resistant infections could cost the global economy $100 trillion by 2050
Features
Drug-resistant infections could cost the global economy $100 trillion by 2050
By Laura LorenzettiDecember 12, 2014
Greg Wasson of Walgreen's in Chicago for Fotune 6-27-13
Retail
Walgreen CEO to leave after Alliance Boots deal in reversal of plan
By Phil WahbaDecember 10, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance
Valeant puts dealmaking on hold to focus on the bottom line
By Laura LorenzettiDecember 9, 2014
Merck takes aim at superbugs with $9.5 billion deal for Cubist
Finance
Merck takes aim at superbugs with $9.5 billion deal for Cubist
By ReutersDecember 8, 2014
BRITAIN-PHARMACEUTICAL-GSK
GSK cuts U.S. research and sales jobs as market gets tougher
By ReutersDecember 4, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
Features
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
Finance
Wynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
After losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
Your pharmacist called. You owe $1.3 trillion.
Features
Your pharmacist called. You owe $1.3 trillion.
By Erika FryNovember 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By Geoffrey SmithNovember 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance
Allergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Cybersecurity
‘This, I’m sorry to say, is just the opening chapter’: Top cyber expert warns of a ‘vulnpocalypse’ after 4 major U.S. systems broke in 6 daysplaceholder alt text
By Nick LichtenbergNovember 18, 2026
AI
The Trump White House is starting to admit that your bank account and airline tickets are under attack from rogue AIplaceholder alt text
By Nick LichtenbergNovember 17, 2026
Personal Finance
Current price of oil as of November 19, 2026placeholder alt text
By Joseph HostetlerNovember 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.